Literature DB >> 1694434

Flow cytogenetics.

M F Bartholdi1.   

Abstract

Applications of flow karyotype analysis and flow chromosome sorting are being developed and are becoming increasingly relevant to clinical research. Among these applications are the quantitative analysis of chromosomal DNA content changes enabling the detection of minute deletions or unbalanced translocations, the quantitative analysis of aneuploidy for trisomy screening, and the sorting of derivative chromosomes for mapping chromosome breakpoints. Flow karyotyping has been accomplished on samples with clinical relevance including peripheral blood from both children and cancer patients as well as amniotic cell cultures. New techniques in flow cytogenetics to resolve chromosomes by morphology or by DNA sequence hybridizations are assessed for their promise. Although flow karyotyping has not yet developed into an 'automated' karyotyping technique, when used in conjunction with classical cytogenetic techniques, new information of significance to the clinician can be produced.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1694434     DOI: 10.1159/000163573

Source DB:  PubMed          Journal:  Pathobiology        ISSN: 1015-2008            Impact factor:   4.342


  4 in total

Review 1.  High-speed chromosome sorting.

Authors:  Sherrif F Ibrahim; Ger van den Engh
Journal:  Chromosome Res       Date:  2004       Impact factor: 5.239

2.  Flow karyotyping and sorting of Vicia faba chromosomes.

Authors:  S Lucretti; J Doležel; I Schubert; J Fuchs
Journal:  Theor Appl Genet       Date:  1993-02       Impact factor: 5.699

Review 3.  Chromosomes in the flow to simplify genome analysis.

Authors:  Jaroslav Doležel; Jan Vrána; Jan Safář; Jan Bartoš; Marie Kubaláková; Hana Simková
Journal:  Funct Integr Genomics       Date:  2012-08-16       Impact factor: 3.410

Review 4.  Chromosome analysis and sorting.

Authors:  Jaroslav Doležel; Sergio Lucretti; István Molnár; Petr Cápal; Debora Giorgi
Journal:  Cytometry A       Date:  2021-02-21       Impact factor: 4.355

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.